{"id":75766,"date":"2021-01-31T23:00:58","date_gmt":"2021-01-31T15:00:58","guid":{"rendered":"https:\/\/www.chinapulse.com\/?p=168020"},"modified":"2021-01-31T23:00:58","modified_gmt":"2021-01-31T15:00:58","slug":"mass-inoculation-shows-safety-efficacy-of-chinese-covid-19-vaccines-top-expert-china","status":"publish","type":"post","link":"https:\/\/www.chinalegalblog.com\/en\/2021\/01\/31\/mass-inoculation-shows-safety-efficacy-of-chinese-covid-19-vaccines-top-expert-china\/","title":{"rendered":"Mass inoculation shows safety, efficacy of Chinese COVID-19 vaccines: top expert  China"},"content":{"rendered":"<p>Video Player Close<\/p>\n<p>GUANGZHOU, Jan. 31 (Xinhua) &#8212; China&#8217;s renowned respiratory-disease expert Zhong Nanshan said Sunday that the mass inoculation of homegrown COVID-19 vaccines underway in China shows the vaccines are safe and effective.<\/p>\n<p>The two vaccines currently in use in China, the China National Biotec Group (CNBG) COVID-19 vaccine and the CoronaVac vaccine developed by China&#8217;s Sinovac Biotech Ltd.,&#8230;<\/p>\n<p>The post <a rel=\"nofollow\" href=\"https:\/\/www.chinapulse.com\/data-news\/2021\/01\/31\/mass-inoculation-shows-safety-efficacy-of-chinese-covid-19-vaccines-top-expert-china\/\">Mass inoculation shows safety, efficacy of Chinese COVID-19 vaccines: top expert  China<\/a> appeared first on <a rel=\"nofollow\" href=\"https:\/\/www.chinapulse.com\/\">ChinaPulse.com<\/a>.<\/p>\n","protected":false},"excerpt":{"rendered":"<p>Video Player Close<br \/>\nGUANGZHOU, Jan. 31 (Xinhua) &#8212; China's renowned respiratory-disease expert Zhong Nanshan said Sunday that the mass inoculation of homegrown COVID-19 vaccines underway in China shows the vaccines are safe and effective.<br \/>\nThe&#8230;<\/p>\n","protected":false},"author":250,"featured_media":0,"comment_status":"closed","ping_status":"closed","sticky":false,"template":"","format":"standard","meta":{"footnotes":""},"categories":[144,213,138,408,194,1542,445],"tags":[7582,3472,10324,7035],"class_list":["post-75766","post","type-post","status-publish","format-standard","hentry","category-china","category-china-news","category-guangdong","category-guangzhou","category-news-chinese-law","category-technology","category-xinhua","tag-biotech","tag-chinese","tag-covid-19","tag-vaccine"],"_links":{"self":[{"href":"https:\/\/www.chinalegalblog.com\/en\/wp-json\/wp\/v2\/posts\/75766"}],"collection":[{"href":"https:\/\/www.chinalegalblog.com\/en\/wp-json\/wp\/v2\/posts"}],"about":[{"href":"https:\/\/www.chinalegalblog.com\/en\/wp-json\/wp\/v2\/types\/post"}],"author":[{"embeddable":true,"href":"https:\/\/www.chinalegalblog.com\/en\/wp-json\/wp\/v2\/users\/250"}],"replies":[{"embeddable":true,"href":"https:\/\/www.chinalegalblog.com\/en\/wp-json\/wp\/v2\/comments?post=75766"}],"version-history":[{"count":1,"href":"https:\/\/www.chinalegalblog.com\/en\/wp-json\/wp\/v2\/posts\/75766\/revisions"}],"predecessor-version":[{"id":75767,"href":"https:\/\/www.chinalegalblog.com\/en\/wp-json\/wp\/v2\/posts\/75766\/revisions\/75767"}],"wp:attachment":[{"href":"https:\/\/www.chinalegalblog.com\/en\/wp-json\/wp\/v2\/media?parent=75766"}],"wp:term":[{"taxonomy":"category","embeddable":true,"href":"https:\/\/www.chinalegalblog.com\/en\/wp-json\/wp\/v2\/categories?post=75766"},{"taxonomy":"post_tag","embeddable":true,"href":"https:\/\/www.chinalegalblog.com\/en\/wp-json\/wp\/v2\/tags?post=75766"}],"curies":[{"name":"wp","href":"https:\/\/api.w.org\/{rel}","templated":true}]}}